Nelleke Snelder

PK/PD modeling of FXI antisense oligonucleotides to bridge the dose‐FXI activity relation from healthy volunteers to end‐stage renal disease patients

Stefan Willmann, Eleonora Marostica, Nelleke Snelder et al. · CPT Pharmacometrics & Systems Pharmacology · 2021 · 39 citations · Full text

Drug effects on the CVS in conscious rats: separating cardiac output into heart rate and stroke volume using<scp>PKPD</scp>modelling

Nelleke Snelder, Bart A. Ploeger, Olivier Luttringer et al. · British Journal of Pharmacology · 2014 · 34 citations · Full text

Population Pharmacokinetic and Exposure–Response Analysis of Finerenone: Insights Based on Phase IIb Data and Simulations to Support Dose Selection for Pivotal Trials in Type 2 Diabetes with Chronic Kidney Disease

Nelleke Snelder, Roland Heinig, Henk‐Jan Drenth et al. · Clinical Pharmacokinetics · 2019 · 28 citations · Full text

<scp>PKPD</scp>modelling of the interrelationship between mean arterial<scp>BP</scp>, cardiac output and total peripheral resistance in conscious rats

Nelleke Snelder, Bart A. Ploeger, Olivier Luttringer et al. · British Journal of Pharmacology · 2013 · 27 citations · Full text

Finerenone Dose–Exposure–Serum Potassium Response Analysis of FIDELIO-DKD Phase III: The Role of Dosing, Titration, and Inclusion Criteria

Sebastiaan C. Goulooze, Nelleke Snelder, Andreas Seelmann et al. · Clinical Pharmacokinetics · 2021 · 26 citations · Full text